Codoxo, a Duluth, Georgia-based provider of AI and generative AI-powered healthcare payment integrity solutions, has raised $35 million in Series C funding.
Investors
The round was led by CVS Health Ventures, with participation from Echo Health Ventures, Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures, and QED Investors. This brings Codoxo’s total funding raised to over $75 million.
CVS Health Ventures is the corporate venture capital arm of CVS Health, established in 2021 to accelerate innovation in the healthcare ecosystem. Launched with an initial $100 million commitment, it invests in high-potential, early-stage companies to accelerate the digital transformation of healthcare.
Codoxo Use of Funds
The company will use the funds to accelerate the deployment of its GenAI-powered Point Zero Payment Integrity platform, scale operations, and enhance payer-provider collaboration for improved payment accuracy.
About Codoxo
Led by CEO Musheer Ahmed, Codoxo is a healthcare technology company providing AI and generative AI solutions for payment integrity. Its Point Zero platform Integrity solutions identify and prevent payment errors before claims are even submitted, stopping issues at their source. Serving health plans covering over 80 million lives, Codoxo’s generative AI-driven platform delivers end-to-end payment integrity and fraud, waste, and abuse (FWA) solutions across the entire payment cycle.
Funding Details
Company: Codoxo, Inc.
Raised: $35.0M
Round: Series C
Funding Date: December 2025
Lead Investor: CVS Health Ventures
Additional Investors: Echo Health Ventures, Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures, QED Investors
Company Website: https://www.codoxo.com/
Software Category: Healthcare AI / Payment Integrity
Source: https://www.businesswire.com/news/home/20251217153568/en/